JPRN-UMIN000004196
Completed
未知
Assessments of the effect of Salmeterol and Fluticasone Propionate (SFC250) on the patients with chronic obstructive pulmonary disease by Impulse Oscillometry - Assessments of the effect of Salmeterol and Fluticasone Propionate (SFC250) on the patients with chronic obstructive pulmonary disease
St. Marianna University School of Medicine, Division of Respiratory and Infectious Diseases0 sites200 target enrollmentSeptember 13, 2010
ConditionsChronic Obstructive Pulmonary Disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease
- Sponsor
- St. Marianna University School of Medicine, Division of Respiratory and Infectious Diseases
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patient is receiving inhaled steroids and long\-acting beta2\-agonists. 2\. Patient is diagnosis as asthma. 3\. Patient is decided as inappropriate for this study by the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Study to examine the effects of Salmeterol/fluticasone propionate combination(SFC) in patients with cough variant asthma(CVA)JPRN-UMIN000002390Kyoto University Graduate School of Medicine60
Completed
Not Applicable
Comparison of Clinical Effects of Salmeterol/Fluticasone Propionate Combination Products Delivered via Metered-Dose Inhaler with Dry Powder Inhaler in Patients with Moderate AsthmaBronchial asthmaJPRN-UMIN000009990ational Center for Global Health and Medicine40
Active, not recruiting
Not Applicable
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studyEUCTR2007-005620-32-LTHEXAL AG472
Active, not recruiting
Phase 1
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studyEUCTR2007-005620-32-PLHEXAL AG472
Active, not recruiting
Not Applicable
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studymoderate-to-severe persistent asthmaMedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2007-005620-32-HUHEXAL AG472